- Home
- GSHD vs OCUL Comparison
GSHD vs OCUL Comparison
Compare GSHD & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GSHD | OCUL |
|---|---|---|
| Founded | 2003 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.9B |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GSHD | OCUL |
|---|---|---|
| Price | $46.09 | $8.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 10 |
| Target Price | ★ $90.00 | $22.33 |
| AVG Volume (30 Days) | 607.8K | ★ 6.9M |
| Earning Date | 05-20-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.04 | N/A |
| Revenue | ★ $365,304,000.00 | $1,990,000.00 |
| Revenue This Year | $19.52 | $10.00 |
| Revenue Next Year | $21.88 | $102.68 |
| P/E Ratio | $42.74 | ★ N/A |
| Revenue Growth | ★ 16.15 | 3.48 |
| 52 Week Low | $42.87 | $5.79 |
| 52 Week High | $127.50 | $16.44 |
Technical Indicators
Market Signals| Indicator | GSHD | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 30.43 | 41.36 |
| Support Level | N/A | $6.78 |
| Resistance Level | $77.70 | $12.63 |
| Average True Range (ATR) | 5.14 | 0.62 |
| MACD | -1.00 | -0.03 |
| Stochastic Oscillator | 13.04 | 54.48 |
Price Performance
Historical ComparisonAbout GSHD Goosehead Insurance Inc.
Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.